The Evidence Speaks (November 2020)
This edition includes deprescribing algorithms for hemodialysis patients, PROMs in fall prevention, and frailty and health after heart valve surgery
Read MoreOctober 28, 2020
The Evidence Speaks Series is a recurring feature highlighting the latest in CHÉOS research. This series features summaries of select publications and is designed to keep the media and the research community up-to-date with CHÉOS’ current research results in the health outcomes field. To ensure this research is quick and easy to share, we are now providing social cards that you are free to save and use as you see fit.
This edition includes deprescribing algorithms for hemodialysis patients, PROMs in fall prevention, and frailty and health after heart valve surgery
Read More
This edition includes major depressive disorder treatment coverage, social connections and hypertension, and paramedic experiences of the overdose response
Read More
This edition includes treatment of out-of-hospital cardiac arrest, implementation of mifepristone medical abortion, and non-traditional factors that contribute to type 2 diabetes
Read More
This COVID-19 special edition includes managing chronic kidney disease, facilitating transcatheter aortic valve implantation, and youth mental health and substance use
Read More
This edition includes TB screening in people starting dialysis, early opioid dispensing after a lower back injury, and the burden and risk factors for HBV, HCV, and HIV in Rwanda
Read More
This edition includes statins and lung cancer risk in COPD, urinary symptoms among women living with HIV, and creating a France–Canada OHCA research network
Read More